mycosis fungoides also known alibertbazin syndrome granuloma common form cutaneous tcell lymphoma generally affects skin may progress internally time symptoms include rash tumors skin lesions itchy skin cause remains unclear cases hereditary cases people years age common men women treatment options include sunlight exposure ultraviolet light topical corticosteroids chemotherapy radiotherapy mycosis fungoides first described french dermatologist jeanlouismarc name mycosis fungoides loosely means mushroomlike fungal disease disease however fungal infection rather type nonhodgkins lymphoma named alibert described skin tumors severe case mushroomlike symptoms mycosis fungoides categorized three clinical stages patch stage plaque stage tumour patch stage defined flat reddish patches varying sizes may wrinkled appearance also look yellowish people darker plaque stage follows patch stage mycosis characterized presence raised lesions appear reddishbrown darker skin tones plaques may greyish silver patch plaque stages considered earlystage mycosis tumour stage typically shows large irregular lumps tumours develop form plaques normal skin region body including face head symptoms displayed progressive early stages consisting lesions presented scaly patches lesions often initially develop trunk body places rarely exposed sun lesions start insignificant patches may remain undiagnosed hypopigmentation skin lighter normal lesions less common found children adolescents andor darkskinned advanced stage mycosis fungoides characterized generalized erythroderma red rash covering body severe pruritus itching itching pruritus commonly reported symptom people experiencing mycosis fungoides people reporting varying intensities pruritus typically worsens disease experience intense pruritus commonly indicate negatively affects quality life emotionally functionally mycosis fungoides mf sézary syndrome ss related conditions type cancer tlymphocytes initially grow different body compartments ss cells found mainly blood whereas mf typically involves skin advanced stages mf cancer cells move skin organs bloodstream progression referred leukemic mycosis fungoides sézary syndrome preceded mycosis fungoides secondary mycosis mycosis fungoides caused abnormal white blood cells tlymphocytes abnormal cells preference localizing proliferating uncontrolled outer layer skin epidermis abnormal cells may later involve organs lymph nodes hypothesized genetic mutations cancer cells lead increased growth escape programmed cell additionally disease unusual expression cells part immune system cells skinassociated meaning biochemically biologically related skin dynamic manner mycosis fungoides common type cutaneous tcell lymphoma ctcl many types ctcl nothing mycosis fungoides disorders treated diagnosis often requires combination clinical pathological studies diagnosis sometimes difficult early phases disease often resemble inflammatory dermatoses eczema psoriasis lichenoid dermatoses including lichen planus vitiligo chronic cutaneous lupus erythematosus well cutaneous several biopsies recommended key microscopic features often absent early mf complete diagnosis requires combination clinical histological furthermore long periods treatment alter biopsy findings making difficult distinguish inflammatory childhood mycosis fungoides makes although data childhood mf limited systematic review observed significant delay diagnosis childhood mf may negatively affect childs prognosis notably pediatric persons mf present earlystage criteria disease established skin biopsy presence stage disease various tests may ordered assess nodes blood internal organs patients present disease apparently confined skin patches flat spots plaques slightly raised wrinkled spots peripheral smear often show buttock traditionally mycosis fungoides divided three stages premycotic mycotic tumorous premycotic stage clinically presents erythematous red itchy scaly lesion microscopic appearance nondiagnostic represented chronic nonspecific dermatosis associated psoriasiform changes epidermismedical citation needed mycotic stage infiltrative plaques appear biopsy shows polymorphous inflammatory infiltrate dermis contains small numbers frankly atypical lymphoid cells cells may line individually along epidermal basal layer latter finding unaccompanied spongiosis highly suggestive mycosis fungoides tumorous stage dense infiltrate mediumsized lymphocytes cerebriform nuclei expands dermis accurate staging mycosis fungoides essential determine appropriate treatment staging based tumor node metastasis blood tnmb classification proposed mycosis fungoides cooperative group revised international society cutaneous lymphomaseuropean organization research treatment staging system examines extent skin involvement presence lymph node n visceral disease presence sezary cells peripheral blood patients mycosis fungoides earlystage disease stage iaiia time initial people early stage disease primarily confined skin favorable people advanced stage stage iibivb often refractory treatment unfavorable treatment options people advanced stage disease designed reduce tumor burden delay disease progression preserve quality commonly recommended firstline treatment mycosis fungoides psoralen plus ultraviolet puva puva photochemotherapy involves topical oral administration photosensitizing drug psoralen followed skin exposure ultraviolet systemic treatments mycosis fungoides often lead resistance additional treatment options often necessary advanced treatments suggested however larger extensive research needed identify effective treatment strategies suggested treatments include light therapy ultraviolet light mainly nbuvb nm topical steroids topical systemic chemotherapies local superficial radiotherapy histone deacetylase inhibitor vorinostat total skin electron radiation photopheresis systemic therapies eg retinoids rexinoids biological therapies eg interferons treatments often used due possible adverse effects treatment options early disease recommended begin therapy topical skindirected treatments progressing systemic us food drug administration granted orphan drug designation naloxone lotion topical opioid receptor competitive antagonist used treatment pruritus cutaneous tcell mogamulizumab monoclonal antibody shown improve progressionfree survival approved us fda use people relapsed refractory mycosis fungoides sézary evidence support use acitretin extracorporeal photopheresis ecp type phototherapy treating people mycosis also evidence support combination treatment puva intralesional ifnα puva treatment adults children mycosis fungoides often differs safety profiles narrowband uvb commonly considered children opposed psoralen uva mechlorethamine hydrochloride oral bexarotene often used usbased study people clls medical records observed relative survival rate relative survival rate years observed relative survival rate remained around poorer survival correlated advanced age black race superior survival observed married women compared gender maritalstatus complete remission rate children nearly rare mycosis fungoides appear age average age onset years age people patch plaque disease people present tumours erythroderma red skin leukemic form sézary syndrome mycosis fungoides common males females differences incidence across various racial groups reported different incidence mycosis fungoides seen increasing although certain regions demonstrated actor mr diagnosed cutaneous tcell lymphoma mycosis remission joked coincidence imagine cancer name personalized popular british television actor paul eddington died mycosis fungoides living condition four aggressive sézary disease httpsenwikipediaorgwikimycosisfungoides